Authors
I Pritsch1; I Tikhonova2; H Jewhurst2; O C Drysdale2; K Cwiklinski2; M Molento1; J P Dalton2; C M Verissimo2;
1 Department of Basic Pathology, Federal University of Parana, Brazil; 2 Queen's University Belfast, UK
Discussion
Cysteine
proteinases are important Fasciola
hepatica virulence molecules. Among
the various cathepsins that F. hepatica
expresses, cathepsin L3 (FhCL3) secreted by the newly excysted juveniles (NEJs)
is of special interest due to its central role in host invasion. Its unique collagenolytic
activity facilitates the rapid passage of the NEJ through the host gut wall. To
protect cells and tissues integrity cathepsins are initially produced as inactive
zymogens whereby the enzyme-specific N-terminal propeptide (pp) is responsible
for regulating the catalytic activity. Accordingly, it has been suggested that
propeptides represent a structural template on which to develop specific
cathepsin inhibitors. Here, differential immunolocalization of the FhCL3 zymogen
and its pp in NEJ’s and immunoblotting of NEJ excretory-secretory products show
that most of FhCL3 zymogen is releasing the pp in the parasite gut. We also investigated
the inhibitory properties and mechanisms of FhCL3 propeptide (ppFhCL3),
revealing that it is a highly potent and selective inhibitor of F. hepatica cathepsin L’s. Using 3-D
structural data we made amino acids substitutions in the ppFhCL3 at residues that
we found are involved in interaction within the propeptide bind loop (PBL) of
the mature enzyme (Tyr46Lys47/Ala46Ala47)
or within the active site (Leu66/Gly66). Our enzyme kinetics
and inhibitory studies unveiled a ‘clamp’ mechanism that is required for the
proper binding and inhibitory activity of the pp to FhCL3. In summary, our
results give remarkable insights regarding the propeptide-cathepsin interaction
and open up the possibility of exploring these features in order to design new
and selective inhibitors for F. hepatica
cathepsins.